Selective uptake of boronated low-density lipoprotein in melanoma xenografts achieved by diet supplementation
1996

Selective Uptake of Boronated LDL in Melanoma

Sample size: 20 publication Evidence: moderate

Author Information

Author(s): Y Setiawan, DE Moore, BJ Allen

Primary Institution: The University of Sydney

Hypothesis

Can boronated low-density lipoprotein (LDL) be used as a targeted drug delivery system for melanoma treatment?

Conclusion

The study demonstrated that diet supplementation can enhance the selective uptake of boronated LDL in melanoma xenografts, achieving a tumor-blood boron concentration ratio of 5:1.

Supporting Evidence

  • Boronated LDL showed a significant increase in tumor uptake compared to control.
  • Diet supplementation with coconut oil and cholesterol improved boron delivery to tumors.
  • The tumor-blood boron concentration ratio achieved was 5:1.

Takeaway

Researchers found that adding certain fats to the diet helped deliver a special type of fat called boronated LDL to tumors better than normal diets.

Methodology

Biodistribution studies were performed in BALB/c mice with subcutaneous melanoma xenografts after diet supplementation and administration of boronated LDL.

Limitations

The study was conducted in mice, and results may not directly translate to humans.

Participant Demographics

Adult male BALB/c mice, 6-8 weeks old.

Statistical Information

P-Value

0.0043

Statistical Significance

p=0.0043

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication